Retinal imaging has evolved over many years thanks to the contributions of ophthalmologists, engineers and companies. However, there are certain important landmarks that have changed the way in which we view and understand the retina. After working on the eye's anatomy and discovering the structures of the eye and retina and their function in good vision, noone can question the importance of understanding ocular imaging.
The first significant discovery came in the middle of the 19th century with the invention of the direct ophthalmoscope by Helmholz in 1851; soon afterwards, in 1852, the inverted-image ophthalmoscope was developed by Ruete. In 1886, the studies of Jackman and Webster produced the first photographs of the human retina by using an ophthalmoscopic mirror -a curved mirror with a centrally located hole -in conjunction with a two-inch microscope objective. This discovery was the beginning of modern imaging of the retina; however, it should be noted that the images were quite blurry.
Improvements in instrumentation and techniques were needed before high-quality fundus photography could become routine. Alongside efforts to obtain quality images of the retina, other studies were being carried out using certain chemicals to allow better visualisation. In 1871, Adolf Baeyer, a 1905 Nobel Laureate in chemistry, described methods for producing a number of new organic dyes -including sodium fluorescein.
Ten years later, fluorescein dye was utilised by Ehrlich to examine the flow of aqueous humour; this was the first published use of sodium fluorescein in ophthalmology. Ehrlich's investigation of fluorescein in the eye was followed in 1910 by Burke, who examined the choroid and retina after the administration of fluorescein dye in coffee. In 1930, Kikai viewed the retina with filtered light in an attempt to more clearly view the injected dye. However, it was not until 1939 that the path of the dye in the retinal blood vessels was described. With this sophisticated digital imaging technology in every primary care office, patients will have access to excellent treatment alternatives.
Indeed, a diagnostic digital retinal imaging device is now available that can take dilated fundus colour-fluorescein angiographic photographs and send the images over the Internet to a centralised reading centre.
The images are examined and interpreted by a team of retina specialists, and the results are sent back to the primary care physician's office immediately.
As mentioned above, affordability is also important. I think this device is an excellent digital retinal camera, and the price is an extra bonus. This cost-effective, advanced design in compact ergonomic technology allows us to achieve high-quality (colour-red-free-fluorescein angiographic) photographic results and comprehensive assessment. I would urge you to make an economic argument for every piece of equipment you are 
